Dr. Sherook J

Dr. Sherook J is an Associate Consultant in Hematology at Fortis Memorial Research Institute, Gurgaon, with over 7 years of dedicated clinical experience in hematology, hemato-oncology, and bone marrow transplantation. He holds advanced qualifications including MBBS, MD, and DM (Doctorate of Medicine in the super-specialty), which equip him to deliver specialized care across the full spectrum of blood disorders and hematological malignancies.

Dr. Sherook's clinical expertise spans complex blood cancers and disorders, including acute and chronic leukemias, lymphomas, multiple myeloma, and myelodysplastic syndromes. He has developed particular proficiency in bone marrow transplantation techniques, including haploidentical bone marrow transplants, and delivers evidence-based chemotherapy and cancer immunotherapy protocols. His clinical approach combines rigorous diagnostic evaluation with individualized treatment planning, enabling him to manage both benign hematological conditions and aggressive malignancies with precision.

Dr. Sherook is well-versed in treating international patients and welcomes referrals from the Gulf region, Africa, and South Asian countries seeking specialized hematological care in India. He works closely with Gaf Healthcare to ensure seamless coordination for overseas patients, offering video consultations, detailed case reviews, and transparent communication throughout the treatment journey. Patients appreciate his patient-centered approach and meticulous attention to clinical outcomes.

Fortis Memorial Research Institute, where Dr. Sherook practices, is a multi-specialty tertiary care center in Gurgaon renowned for its oncology and transplant programs. The institute maintains world-class infrastructure, accreditation standards, and a dedicated international patient services desk that facilitates visa, accommodation, and logistics support. Its commitment to research-driven clinical practice and infection prevention makes it a preferred destination for complex hematological cases. International patients benefit from the hospital's experience managing cross-border referrals and its robust post-treatment follow-up protocols.